Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 21, 2022 at 03:24 pm EST
Share
Kaya Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.172968 million compared to USD 0.214051 million a year ago. Net loss was USD 7.41 million compared to net income of USD 3.95 million a year ago. Basic loss per share from continuing operations was USD 0.5 compared to basic earnings per share from continuing operations of USD 0.26 a year ago.
For the nine months, sales was USD 0.556818 million compared to USD 0.690267 million a year ago. Net loss was USD 5.39 million compared to net income of USD 7.61 million a year ago. Basic loss per share from continuing operations was USD 0.37 compared to basic earnings per share from continuing operations of USD 0.52 a year ago. Diluted loss per share from continuing operations was USD 0.37 compared to diluted earnings per share from continuing operations of USD 0.11 a year ago.
Kaya Holdings, Inc is a holding company. The Company is focused on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and cannabidiol (CBD) products. The Company produces, distributes, and/or sells a full range of cannabis products including flowers, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands. It operates through four subsidiaries, which include Marijuana Holdings Americas, Inc. (MJAI), Kaya Brand International, Inc. (KBI)., and Fifth Dimension Therapeutics, Inc. (FDT). MJAI maintains ownership of the Companyâs Oregon-based cannabis operations. FDT provides psychedelic mind care treatments to veterans suffering from PTSD, addicts seeking to break addiction, individuals with eating disorders, and others with an array of treatment resistant mental health disorders.